MED Stock Overview
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Medartis Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF80.90 |
| 52 Week High | CHF99.40 |
| 52 Week Low | CHF63.50 |
| Beta | 0.97 |
| 1 Month Change | -0.61% |
| 3 Month Change | 9.62% |
| 1 Year Change | 10.37% |
| 3 Year Change | 11.59% |
| 5 Year Change | 42.43% |
| Change since IPO | 30.57% |
Recent News & Updates
Recent updates
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation
Apr 11
The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence
Feb 14Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Oct 24Is Medartis Holding (VTX:MED) A Risky Investment?
Oct 03Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 06Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)
Jun 21Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital
Jan 31Why Medartis Holding AG (VTX:MED) Could Be Worth Watching
Oct 30These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat
Sep 07When Should You Buy Medartis Holding AG (VTX:MED)?
Jul 29Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
May 06At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?
Feb 08Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Jan 18We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt
Nov 10Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
Sep 29Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital
Jun 08How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?
Mar 16We're Watching These Trends At Medartis Holding (VTX:MED)
Feb 09
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain
Jan 04What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?
Nov 19Shareholder Returns
| MED | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | -0.7% | 0.4% | 2.0% |
| 1Y | 10.4% | 5.6% | -2.8% |
Return vs Industry: MED exceeded the Swiss Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: MED exceeded the Swiss Market which returned -4% over the past year.
Price Volatility
| MED volatility | |
|---|---|
| MED Average Weekly Movement | 5.8% |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.3% |
| 10% least volatile stocks in CH Market | 1.9% |
Stable Share Price: MED has not had significant price volatility in the past 3 months.
Volatility Over Time: MED's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 812 | Christoph Bronnimann | www.medartis.com |
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names.
Medartis Holding AG Fundamentals Summary
| MED fundamental statistics | |
|---|---|
| Market cap | CHF1.10b |
| Earnings (TTM) | CHF619.00k |
| Revenue (TTM) | CHF212.01m |
1,772x
P/E Ratio5.2x
P/S RatioIs MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MED income statement (TTM) | |
|---|---|
| Revenue | CHF212.01m |
| Cost of Revenue | CHF44.43m |
| Gross Profit | CHF167.57m |
| Other Expenses | CHF166.95m |
| Earnings | CHF619.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 20, 2024
| Earnings per share (EPS) | 0.046 |
| Gross Margin | 79.04% |
| Net Profit Margin | 0.29% |
| Debt/Equity Ratio | 0.2% |
How did MED perform over the long term?
See historical performance and comparison